Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Will be looking for data soon after!

$Catheter Precision (VTAK.US)$ Catheter Precision, Inc. Completes Enrollment Of 75 Patients In Its LockeT-II Study, Which Is Expected To Conclude In Oct. 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
2
+0
1
Translate
Report
5129 Views
Comment
Sign in to post a comment
  • andy(三叔) : July 25 (Reuters) - Predictive Oncology Inc poai.o:

    July 25 (Reuters) — Prediction Oncology Company PoAI.o:

    Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

    PREDICTIVE ONCOLOGY ENTERS BIOMARKER DISCOVERY MARKET AFTER SUCCESSFUL REVIEW OF OVARIAN CANCER STUDY YIELDS CONVINCING RESULTS

    Source Text for Eikon: ID: NGNX5st8ff

    Source text for Eikon: ID: NGNX5st8FF

    Further Company Coverage: Poai.o

    More company reports: Poai.o

3468Followers
27Following
52KVisitors
Follow